Chartis System

May 20, 2016May 20, 2016

Follow-up Data from Study of EBV Treatment in Emphysema Patients Shows Lasting Benefits

Emphysema, News

Pulmonx Corporation reported positive one-year data from the STELVIO trial, the first randomized study evaluating the Zephyr Endobronchial Valve (EBV) in people with severe emphysema, who were selected using the diagnostic Chartis System to identify ... Read more

March 21, 2016March 21, 2016

Experts Recommend Zephyr EBV as Only Minimally Invasive Emphysema Treatment for Use Outside Clinical Trials

Emphysema, News

Pulmonx, based in Redwood City, California, recently announced the publication of recommendations from a panel of experts offering broad guidance regarding selection of therapies for patients with advanced emphysema. The panel recommended that only ... Read more

December 14, 2015December 14, 2015

Advanced Emphysema Patients Respond Well to EBV Therapy in Study

Emphysema, News

Results from the STELVIO trial involving a combination of Zephyr EBV therapy with the Chartis System diagnostic tool revealed significant improvements for patients with severe emphysema. The results were published ... Read more